Sayuri Akiyoshi
Fukuoka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Prospective observational study of atezolizumab plus nab-paclitaxel in patients with metastatic triple-negative breast cancer: JBCRG-C08/ATTRIBUTE.
Journal: NPJ breast cancer
Published: November 03, 2025
Optimizing Antiemetic Support in Anthracycline-Based Chemotherapy for Early Breast Cancer: Protocol for a Prospective Observational Study of Four-Drug Antiemetic Therapy Including Fosnetupitant and Olanzapine.
Journal: JMIR research protocols
Published: October 14, 2025
The impact of breast surgery and systemic therapy on the survival of patients with de novo stage IV breast cancer.
Journal: Breast cancer (Tokyo, Japan)
Published: September 04, 2024
A dramatic response to an immune checkpoint inhibitor plus chemotherapy in a patient with metastatic metaplastic carcinoma of the breast: A case report.
Journal: Thoracic cancer
Published: June 03, 2024
Bilateral breast metastases from anaplastic lymphoma kinase-positive lung cancer in a male: a case report.
Journal: Journal of medical case reports
Published: March 18, 2024
Amide proton transfer (APT) imaging of breast cancers and its correlation with biological status.
Journal: Clinical imaging
Published: October 13, 2022
MUC1-C Dictates PBRM1-Mediated Chronic Induction of Interferon Signaling, DNA Damage Resistance, and Immunosuppression in Triple-Negative Breast Cancer.
Journal: Molecular cancer research : MCR
Published: September 30, 2022
Reliability, validity, and responsiveness of the Japanese version of the EORTC QLQ-ELD14 in evaluating the health-related quality of life of elderly patients with cancer.
Journal: Journal of cancer research and clinical oncology
Published: July 10, 2022
Comprehensive molecular profiling broadens treatment options for breast cancer patients.
Journal: Cancer medicine
Published: August 20, 2020
Effects of Diluent Volume and Administration Time on the Incidence of Anaphylaxis Following Docetaxel Therapy in Breast Cancer.
Journal: Biological & pharmaceutical bulletin
Published: April 03, 2020
CD44v9 as a poor prognostic factor of triple-negative breast cancer treated with neoadjuvant chemotherapy.
Journal: Breast cancer (Tokyo, Japan)
Published: December 27, 2017
Last Updated: 09/26/2026